No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy-Reference-Cited by-同舟云学术

No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy

Published:2019-03-07 Issue:6 Volume:66 Page:e27681
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Robinson Katherine M.¹,Yang Wenjian¹,Karol Seth E.²,Kornegay Nancy¹,Jay Dennis³,Cheng Cheng⁴,Choi John K.³,Campana Dario⁵,Pui Ching‐Hon²^ORCID,Wood Brent⁶,Borowitz Michael J.⁷,Gastier‐Foster Julie⁸,Larsen Eric C.⁹,Winick Naomi¹⁰,Carroll William L.¹¹^ORCID,Loh Mignon L.¹²,Raetz Elizabeth A.¹¹,Hunger Stephen P.¹³,Devidas Meenakshi¹⁴,Mardis Elaine R.⁸,Fulton Robert S.¹⁵,Relling Mary V.¹^ORCID,Jeha Sima²

Affiliation:

1. Department of Pharmaceutical SciencesSt. Jude Children's Research Hospital Memphis Tennessee

2. Department of OncologySt. Jude Children's Research Hospital Memphis Tennessee

3. Department of PathologySt. Jude Children's Research Hospital Memphis Tennessee

4. Department of BiostatisticsSt. Jude Children's Research Hospital Memphis Tennessee

5. Department of PaediatricsNational University of Singapore Singapore

6. Department of Laboratory MedicineSeattle Children's Hospital Seattle Washington

7. Department of Hematologic PathologyJohn's Hopkins University Baltimore Maryland

8. Nationwide Children's HospitalThe Ohio State University Columbus Ohio

9. Department of Pediatric Hematology‐OncologyMaine Medical Center Scarborough Maine

10. Department of PediatricsUT Southwestern Medical Center Dallas Texas

11. Perlmutter Cancer CenterDepartment of PediatricsNYU Langone Medical Center New York City New York

12. Department of PediatricsBenioff Children's Hospital and the Helen Diller Family Comprehensive Cancer CenterUniversity of California San Francisco San Francisco California

13. Department of PediatricsChildren's Hospital of Philadelphia Philadelphia Pennsylvania

14. Department of BiostatisticsUniversity of Florida Gainesville Florida

15. Department of GeneticsWashington University School of Medicine St. Louis Missouri

Funder

National Institutes of Health

St. Baldrick's Foundation

American Lebanese Syrian Associated Charities

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27681

Reference20 articles.

1. Adriamycin and daunomycin generate reactive oxygen compounds in erythrocytes;Henderson CA;Blood,1978

2. The effect of BCNU and adriamycin on normal and G6PD deficient erythrocytes

3. Oxidant Stress and Haemolysis of the Human Erythrocyte

4. Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

5. The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw‐Hill New York City LMA Luzzatto A Mehta T Vulliamy AL Beaudet CR Scriver WS Sly D Valle Chapter 179: Glucose 6‐phosphate dehydrogenase deficiency 4517‐4553

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mandatory role of endoplasmic reticulum and its pentose phosphate shunt in the myocardial defense mechanisms against the redox stress induced by anthracyclines;Molecular and Cellular Biochemistry;2023-12-12

2. A rare adverse effects of COVID-19 vaccine in a patient with a latent tumor: A case report and literature review;Frontiers in Oncology;2023-12-05

3. Identification of Prognostic and Predictive Biomarkers and Druggable Targets among 205 Antioxidant Genes in 21 Different Tumor Types via Data-Mining;Pharmaceutics;2023-01-28

4. Pharmacogenetics, Pharmacogenomics, and Precision Medicine;Drug Disposition and Pharmacokinetics;2022-09-30

5. Incorporating G6PD genotyping to identify patients with G6PD deficiency;Pharmacogenetics and Genomics;2021-10-22